The healthcare provider reported net profit of Rs 141.7 crore in the corresponding quarter of the previous year.
The earnings before interest, tax, depreciation and ammortisation (EBITDA) dropped 2% year-on-year (YoY) to Rs 288 crore. The EBITDA margins declined 150 basis points to 18.5%.
Hospital revenues, which constitutes over 80% of overall revenues increased 13.3% year-on-year (YoY) to Rs 1,267.4 led by an 8.4% increase in average revenue per occupied bed (ARPOB) to Rs 2.02 crore, better occupancy and a 73% rise in international patient revenues.
The occupancy stood at 66.1% and average length of stay (ALOS) was at 3.77 days.
Diagnostics business revenues declined 11% YoY to Rs 331.5 crore in Q3 FY22, primarily impacted by lower covid volumes. Revenues for the quarter excluding covid and covid allied tests stood at Rs 321 crores.
